Medeon Biodesign is pleased to announce that its innovative laparoscopic port site closure device, AbClose™, successfully closed more than 50 wounds in a variety of laparoscopic surgeries. The device consistently demonstrated its simplicity, stability and predictability in the hands of multiple physicians in an ongoing pre-commercial clinical evaluation in the United States. The U.S. Food and Drug Administration 510(k) cleared …
Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States

Recent Comments